Caisse de Depot et Placement du Quebec (CDPQ)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.8M | Buy |
85,748
+83,760
| +4,213% | +$25.3M | 0.04% | 365 |
|
|
2026
Q1 | $658K | Sell |
1,988
-49,610
| -96% | -$16.9M | ﹤0.01% | 631 |
|
|
2025
Q4 | $20.5M | Buy |
51,598
+33,772
| +189% | +$14.9M | 0.03% | 357 |
|
|
2025
Q3 | $8.13M | Sell |
17,826
-2,218
| -11% | -$903K | 0.01% | 407 |
|
|
2025
Q2 | $6.54M | Sell |
20,044
-3,719
| -16% | -$1.03M | 0.01% | 391 |
|
|
2025
Q1 | $6.42M | Buy |
23,763
+13,745
| +137% | +$3.53M | 0.01% | 428 |
|
|
2024
Q4 | $2.36M | Sell |
10,018
-15,277
| -60% | -$4.02M | ﹤0.01% | 472 |
|
|
2024
Q3 | $6.96M | Hold |
25,295
| – | – | 0.01% | 360 |
|
|
2024
Q2 | $6.15M | Buy |
25,295
+500
| +2% | +$78.9K | 0.01% | 350 |
|
|
2024
Q1 | $3.71M | Buy |
24,795
+5,200
| +27% | +$867K | 0.01% | 397 |
|
|
2023
Q4 | $3.75M | Buy |
19,595
+6,884
| +54% | +$1.17M | 0.01% | 396 |
|
|
2023
Q3 | $2.25M | Hold |
12,711
| – | – | 0.01% | 385 |
|
|
2023
Q2 | $2.41M | Sell |
12,711
-2,189
| -15% | -$434K | 0.01% | 385 |
|
|
2023
Q1 | $2.98M | Hold |
14,900
| – | – | 0.01% | 428 |
|
|
2022
Q4 | $3.54M | Buy |
+14,900
| New | +$3.18M | 0.01% | 433 |
|
|
2022
Q3 | – | Sell |
-1,794
| Closed | -$262K | – | 550 |
|
|
2022
Q2 | $262K | Buy |
+1,794
| New | +$255K | ﹤0.01% | 567 |
|
|
2021
Q2 | – | Sell |
-1,687
| Closed | -$238K | – | 519 |
|
|
2021
Q1 | $238K | Sell |
1,687
-38,936
| -96% | -$5.86M | ﹤0.01% | 667 |
|
|
2020
Q4 | $5.28M | Buy |
40,623
+37,923
| +1,405% | +$5.06M | 0.01% | 285 |
|
|
2020
Q3 | $393K | Sell |
2,700
-200
| -7% | -$28.4K | ﹤0.01% | 639 |
|
|
2020
Q2 | $430K | Sell |
2,900
-1,200
| -29% | -$162K | ﹤0.01% | 640 |
|
|
2020
Q1 | $446K | Hold |
4,100
| – | – | ﹤0.01% | 666 |
|
|
2019
Q4 | $472K | Sell |
4,100
-1,300
| -24% | -$130K | ﹤0.01% | 655 |
|
|
2019
Q3 | $434K | Buy |
5,400
+200
| +4% | +$15.8K | ﹤0.01% | 779 |
|
|
2019
Q2 | $377K | Sell |
5,200
-300
| -5% | -$23K | ﹤0.01% | 734 |
|
|
2019
Q1 | $514K | Sell |
5,500
-184,500
| -97% | -$15.4M | ﹤0.01% | 686 |
|
|
2018
Q4 | $13.9M | Buy |
190,000
+187,300
| +6,937% | +$14.4M | 0.04% | 195 |
|
|
2018
Q3 | $236K | Sell |
2,700
-100
| -4% | -$10.1K | ﹤0.01% | 754 |
|
|
2018
Q2 | $276K | Buy |
+2,800
| New | +$278K | ﹤0.01% | 757 |
|
|
2016
Q4 | – | Sell |
-9,500
| Closed | -$644K | – | 686 |
|
|
2016
Q3 | $644K | Sell |
9,500
-700
| -7% | -$49.4K | ﹤0.01% | 672 |
|
|
2016
Q2 | $566K | Buy |
10,200
+4,900
| +92% | +$309K | ﹤0.01% | 726 |
|
|
2016
Q1 | $333K | Buy |
+5,300
| New | +$352K | ﹤0.01% | 747 |
|
Other funds holding ALNY
Caisse de Depot et Placement du Quebec (CDPQ)'s ALNY Position: Q2 2026 in Review
Caisse de Depot et Placement du Quebec (CDPQ) increased its Alnylam Pharmaceuticals (ALNY) stake by 4,213% in Q2 2026, buying an estimated $25.3M and bringing the position to 85,748 shares worth $25.8M. The position accounts for 0.04% of the portfolio, ranked #365.
Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in ALNY in Q1 2016 and has held it in 31 quarters since. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- Caisse de Depot et Placement du Quebec (CDPQ) held 85,748 shares of Alnylam Pharmaceuticals worth $25.8M as of Q2 2026.
- Caisse de Depot et Placement du Quebec (CDPQ) bought 83,760 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $25.3M.
- Alnylam Pharmaceuticals made up 0.04% of Caisse de Depot et Placement du Quebec (CDPQ)'s portfolio in Q2 2026, its #365 holding.
- Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Alnylam Pharmaceuticals in Q1 2016 and has held it in 31 quarters since.
- 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q2 2026, filed 14 Aug 2026.